Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension
Bin Zhou, Pablo Perel, George A. Mensah, et al.
Nature Reviews Cardiology (2021) Vol. 18, Iss. 11, pp. 785-802
Open Access | Times Cited: 984

Showing 1-25 of 984 citing articles:

Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants
Bin Zhou, Rodrigo M. Carrillo‐Larco, Goodarz Danaei, et al.
The Lancet (2021) Vol. 398, Iss. 10304, pp. 957-980
Open Access | Times Cited: 2509
2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension
Giuseppe Mancia, Reinhold Kreutz, Mattias Brunström, et al.
Journal of Hypertension (2023) Vol. 41, Iss. 12, pp. 1874-2071
Open Access | Times Cited: 1600
The sirtuin family in health and disease
Qi‐Jun Wu, Tie‐Ning Zhang, Huanhuan Chen, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 408
Hypertension in China: epidemiology and treatment initiatives
Ji‐Guang Wang, Ying Zhang, Yan Li, et al.
Nature Reviews Cardiology (2023) Vol. 20, Iss. 8, pp. 531-545
Closed Access | Times Cited: 100
Immune and inflammatory mechanisms in hypertension
Tomasz J. Guzik, Ryszard Nosalski, Pasquale Maffia, et al.
Nature Reviews Cardiology (2024) Vol. 21, Iss. 6, pp. 396-416
Closed Access | Times Cited: 92
Cardiovascular diseases in Africa in the twenty-first century: Gaps and priorities going forward
Neema W. Minja, Doreen Nakagaayi, Twalib Aliku, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 86
Addressing global disparities in blood pressure control: perspectives of the International Society of Hypertension
Aletta E. Schutte, Tazeen H. Jafar, Neil R Poulter, et al.
Cardiovascular Research (2022) Vol. 119, Iss. 2, pp. 381-409
Open Access | Times Cited: 80
Global burden of metabolic diseases, 1990–2021
Huai Zhang, Xiaodong Zhou, Michael D. Shapiro, et al.
Metabolism (2024) Vol. 160, pp. 155999-155999
Closed Access | Times Cited: 75
Steviol Glycosides from Stevia rebaudiana: An Updated Overview of Their Sweetening Activity, Pharmacological Properties, and Safety Aspects
Adriana Orellana-Paucar
Molecules (2023) Vol. 28, Iss. 3, pp. 1258-1258
Open Access | Times Cited: 61
The neutrophil-to-lymphocyte ratio is associated with all-cause and cardiovascular mortality among individuals with hypertension
Xuexue Zhang, Rui Wei, Xujie Wang, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 53
A major mechanism for immunomodulation: Dietary fibres and acid metabolites
Liang Xie, Jahangir Alam, Francine Z. Marques, et al.
Seminars in Immunology (2023) Vol. 66, pp. 101737-101737
Open Access | Times Cited: 50
Long-Term Cardiovascular Outcomes in Children and Adolescents With Hypertension
Cal Robinson, Junayd Hussain, Nivethika Jeyakumar, et al.
JAMA Pediatrics (2024) Vol. 178, Iss. 7, pp. 688-688
Closed Access | Times Cited: 23
The triglyceride–glucose index and its obesity-related derivatives as predictors of all-cause and cardiovascular mortality in hypertensive patients: insights from NHANES data with machine learning analysis
Chenyang Li, Zixi Zhang, Xiao-Qin Luo, et al.
Cardiovascular Diabetology (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 7
A peptide from Boletus griseus‐Hypomyces chrysospermus protects against hypertension and associated cardiac and renal damage through modulating RAAS and intestinal microbiota
Pengtao Huan, Liping Sun, Shupeng Chen, et al.
Journal of Food Science (2025) Vol. 90, Iss. 1
Closed Access | Times Cited: 2
Association of sleep duration with hypertension in young and middle-aged adults: A systematic review and meta-analysis
Lei Yang, Fang-Xiao Hu, Kun Wang, et al.
International Journal of Cardiology Cardiovascular Risk and Prevention (2025) Vol. 25, pp. 200387-200387
Open Access | Times Cited: 2
Berberine: A Review of its Pharmacokinetics Properties and Therapeutic Potentials in Diverse Vascular Diseases
Xiaopeng Ai, Peiling Yu, Li‐Xia Peng, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 97
Independent Associations of Education, Intelligence, and Cognition With Hypertension and the Mediating Effects of Cardiometabolic Risk Factors: A Mendelian Randomization Study
Yiying Wang, Chaojie Ye, Lijie Kong, et al.
Hypertension (2022) Vol. 80, Iss. 1, pp. 192-203
Open Access | Times Cited: 66
How Much Lowering of Blood Pressure Is Required to Prevent Cardiovascular Disease in Patients With and Without Previous Cardiovascular Disease?
Dexter Canoy, Milad Nazarzadeh, Emma Copland, et al.
Current Cardiology Reports (2022) Vol. 24, Iss. 7, pp. 851-860
Open Access | Times Cited: 56
Machine Learning Approaches for Predicting Hypertension and Its Associated Factors Using Population-Level Data From Three South Asian Countries
Sheikh Mohammed Shariful Islam, Ashis Talukder, Md. Abdul Awal, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 55
Modeling global 80-80-80 blood pressure targets and cardiovascular outcomes
Sarah Pickersgill, William Msemburi, Laura K. Cobb, et al.
Nature Medicine (2022) Vol. 28, Iss. 8, pp. 1693-1699
Open Access | Times Cited: 48
Hypertension is prevalent in non-alcoholic fatty liver disease and increases all-cause and cardiovascular mortality
Cheng Han Ng, Zhen Yu Wong, Nicholas Chew, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 47
Urban-rural differences in hypertension prevalence in low-income and middle-income countries, 1990–2020: A systematic review and meta-analysis
Otávio T. Ranzani, Anjani Kalra, Chiara Di Girolamo, et al.
PLoS Medicine (2022) Vol. 19, Iss. 8, pp. e1004079-e1004079
Open Access | Times Cited: 47
High Blood Pressure in Children and Adolescents: Current Perspectives and Strategies to Improve Future Kidney and Cardiovascular Health
Cal Robinson, Rahul Chanchlani
Kidney International Reports (2022) Vol. 7, Iss. 5, pp. 954-970
Open Access | Times Cited: 46
Seven‐action approaches for the management of hypertension in Asia – The HOPE Asia network
Kazuomi Kario, Yook Chin Chia, Saulat Siddique, et al.
Journal of Clinical Hypertension (2022) Vol. 24, Iss. 3, pp. 213-223
Open Access | Times Cited: 41
RNA modification in cardiovascular disease: implications for therapeutic interventions
Cong Wang, Xuyang Hou, Qing Guan, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 31
Page 1 - Next Page

Scroll to top